Approved drugs are to be studied for use in Alzheimer’s diseaseBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i5063 (Published 19 September 2016) Cite this as: BMJ 2016;354:i5063
- Janice Hopkins Tanne
- New York
Many drugs that have been approved by the Food and Drug Administration could be repurposed or used off label to treat Alzheimer’s disease, according to reports from the Alzheimer’s Drug Discovery Foundation conference in New Jersey.
The foundation is supporting 18 approved drugs in repurposing trials. This brings the total number of approved drugs that were being studied for use in treating Alzheimer’s disease in repurposing trials to at least 127, the foundation said.
The drugs discussed at a press briefing on 13 September were tadalafil (Cialis), approved to treat erectile dysfunction, and levetiracetam (Keppra), approved to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial